Living Microbial Therapeutics for Health & Agriculture
We develop precision microbial consortia that restore gut ecology, rebalance skin health, and rehabilitate depleted soils, backed by $6.8M in federal research funding.
SciNet Industries is a fictional company created for demonstration purposes. Any resemblance to actual companies, persons, or products is entirely coincidental.
Restore & Strengthen Human Health Through Living Microbial Ecosystems
Founded in 2017 as a Johns Hopkins University spinout, SciNet Industries develops precision microbiome therapeutics and diagnostic platforms that restore microbial balance across human health, from chronic gut conditions to degraded agricultural soils.
Our technology restores native microbial ecosystems, enables early dysbiosis detection through AI-driven diagnostics, and engineers targeted probiotic therapies, all backed by nine federal research awards totaling over $6.8 million.
Elena Vasquez
CEO & Founder · MIT Technology Review Innovator Under 35
2017
Founded
$6.8M
Federal Funding
9
SBIR Awards
5
Technology Areas
Five Platforms, One Mission
From precision consortia to AI-driven diagnostics, our technology portfolio addresses critical challenges across clinical medicine, public health, and regenerative agriculture.
FLORACORE
Precision Consortia
Rationally designed microbial consortia that restore gut ecology in patients with recurrent C. difficile and inflammatory bowel disease. Strain-specific formulations calibrated to individual dysbiosis profiles.
DERMABIOME
Topical Therapeutics
Live biotherapeutic skin formulations that rebalance the cutaneous microbiome. Targeting chronic eczema, acne, and wound healing by reintroducing commensal organisms displaced by conventional treatments.
Predictive Dysbiosis Engine
Diagnostic AI
Machine learning platform that maps metagenomic sequencing data to disease risk scores. Identifies microbial imbalance signatures months before clinical symptoms appear, enabling preventive intervention.
SynthBiome
Engineered Probiotics
Next-generation probiotic strains engineered for targeted metabolite production — short-chain fatty acids, tryptophan derivatives, and bile acid modulators — to address metabolic and neurological conditions.
TerraSync
Agricultural Microbiomics
Soil microbiome restoration products for regenerative agriculture. Reintroduces native microbial communities to depleted farmland, reducing synthetic fertilizer dependence and improving crop resilience.
Backed by Federal Research
Trusted by the National Institutes of Health, DARPA, the USDA, and the National Science Foundation.
$6.8M
Total Funding
9
SBIR Awards
4
Federal Agencies
Microbial consortia for recurrent C. difficile infection
2018
Gut-brain axis modulation via targeted probiotics
2019
Metagenomic diagnostic platform development
2019
FLORACORE clinical trials — IBD cohort
2020
Warfighter gut resilience under operational stress
2021
Soil microbiome restoration for degraded cropland
2021
Live biotherapeutic topicals for atopic dermatitis
2022
Microbiome-immunotherapy synergy in solid tumors
2023
SynthBiome metabolic disorder intervention trial
2023
Where Science Meets Life
Our technologies deploy across clinical medicine, precision diagnostics, and regenerative agriculture, wherever microbial ecosystems shape outcomes.
Clinical
- Recurrent C. difficile infection treatment
- Inflammatory bowel disease management
- Atopic dermatitis & chronic skin conditions
- Immuno-oncology microbiome support
Diagnostics
- Predictive dysbiosis risk scoring
- Metagenomic sequencing analysis
- Gut-brain axis biomarker detection
- Treatment response stratification
Agriculture
- Soil microbiome rehabilitation
- Synthetic fertilizer reduction programs
- Crop resilience & yield optimization
- Regenerative farming consortia
Trusted Collaborators
We work alongside leading research institutions, accelerators, and industry partners to bring lab science to the field.
Johns Hopkins University
Academic
BioHealth Innovation
Accelerator
Whole Biome Inc.
Industry
Marine Biological Laboratory
Research
Elena Vasquez
MIT Technology Review Innovator Under 35
Let's Talk Microbiome Science
Ready to explore how microbial therapeutics can address your toughest health challenges?
Location
1200 Fayette St, Suite 400, Baltimore, MD 21230
Connect
LinkedIn(opens in new tab)SciNet Industries is a Johns Hopkins University spinout specializing in microbiome therapeutics for clinical and agricultural applications. We work with federal agencies, research institutions, and healthcare partners to bring living microbial solutions from the lab to the patient.